United States Acute Intermittent Porphyria Market Analysis and Future Growth Prospects
The United States represents the largest share of the Acute Intermittent Porphyria Market, driven by its advanced healthcare infrastructure, robust rare disease research ecosystem, and widespread availability of innovative therapies. The country benefits from strong support for orphan drug development … Read more